This document discusses antibiotic therapy for musculoskeletal infections. It begins by outlining the learning objectives which are to discuss musculoskeletal infections, antibiotic recommendations, periprosthetic infections, and prophylactic antibiotic therapy. It then covers topics like the types of musculoskeletal infections, factors to consider when selecting antibiotics, common routes of administration, organisms associated with different infections, and treatment guidelines. It provides treatment recommendations for various pathogens. It concludes by listing some commonly used antibiotics for musculoskeletal infections and their characteristics.
This document discusses macrolide antibiotics. It defines macrolides as antibiotics containing a macrocyclic lactone ring and attached sugars. It lists common macrolides including erythromycin, azithromycin, clarithromycin, and roxithromycin. It describes the mechanism of action as inhibiting bacterial protein synthesis and discusses their uses for treating respiratory infections, atypical pneumonia, and more. Common side effects include gastrointestinal issues. Azithromycin is highlighted as having expanded spectrum, improved pharmacokinetics, and convenient once daily dosing.
Antibiotic selection /certified fixed orthodontic courses by Indian dental ...Indian dental academy
This document provides information on antibiotics used for head and neck infections. It discusses the history of antibiotic discovery, classifications of antibiotics based on mechanism of action and type of organism affected, considerations for antibiotic selection such as host defenses and infection characteristics, administration principles, and potential adverse reactions. The key factors in selecting an appropriate antibiotic include the typical mixed aerobic-anaerobic oral flora, penicillin as first-line therapy, narrow-spectrum use, and parenteral administration for serious infections.
This document summarizes various antiviral drugs used to treat different viral infections. It discusses the mechanism of action, uses, and side effects of nucleoside analogues like acyclovir, valacyclovir, ganciclovir, cidofovir and ribavirin which inhibit viral DNA or RNA polymerase. It also mentions neuraminidase inhibitors oseltamivir and zanamivir used for influenza, and lamivudine, entecavir, tenofovir for chronic hepatitis B. Interferon-α used with ribavirin for hepatitis C treatment is also summarized.
Antibiotics in oral and maxillofacial surgery Firas Kassab
The document discusses antibiotics and their mechanisms and uses. It provides information on the history of antibiotics including discoveries by Pasteur, Fleming, Chain and Florey. It classifies antibiotics as bactericidal or bacteriostatic and lists examples of each. The mechanisms of different classes of antibiotics are described such as inhibiting cell wall synthesis or protein synthesis. Guidelines for antibiotic selection and factors like host defenses, toxicity, and cost are covered. Information on specific antibiotics for different infections is provided.
This document discusses cephalosporins, a class of antibiotics. It describes the different generations of cephalosporins and their antibacterial spectra. Some key points covered include: cephalosporins have similar mechanisms and resistance as penicillin; common side effects include hypersensitivity, diarrhea, and nephrotoxicity; uses include respiratory, urinary, and skin infections as well as surgical prophylaxis and meningitis; and examples are provided of cephalosporins with anti-anaerobic or anti-pseudomonal activity.
Antibiotics in oral and maxillofacial surgery /certified fixed orthodontic co...Indian dental academy
This document discusses the use of antibiotics in oral and maxillofacial surgery. It begins with definitions and classifications of antibiotics. It then covers the history of antibiotic development. The document discusses principles for choosing antibiotics, including the state of a patient's defenses, using the narrowest effective spectrum, cost, and proven efficacy. It addresses administration principles like proper dosing and timing. The therapeutic uses of various antibiotics for conditions like abscesses, osteomyelitis, and salivary gland infections are analyzed. Special considerations for pregnancy, children, liver/kidney disease are also covered. The document concludes with sections on antibiotic prophylaxis and misuse.
Vancomycin is a glycopeptide antibiotic used to treat infections caused by gram-positive bacteria such as MRSA. This 3-page document provides guidelines on vancomycin dosing and monitoring for different patient populations including neonates, infants, children, and patients with renal impairment. It outlines dosing recommendations according to indication, administration methods, monitoring for toxicity, and renal function-based dosing adjustments.
This document discusses various types of beta-lactam antibiotics including penicillins and cephalosporins. It provides information on:
- Quinolones exhibit a long post-antibiotic effect while cefpirome is a 4th generation cephalosporin.
- All drugs listed are administered orally except gentamicin. Sulbactam is not a beta-lactamase inhibitor.
- Mechanisms of action, resistance, classifications, uses, pharmacokinetics and adverse effects of different beta-lactam antibiotics like penicillins, cephalosporins, carbapenems are explained in detail. Beta-lactamase inhibitors
This document discusses macrolide antibiotics. It defines macrolides as antibiotics containing a macrocyclic lactone ring and attached sugars. It lists common macrolides including erythromycin, azithromycin, clarithromycin, and roxithromycin. It describes the mechanism of action as inhibiting bacterial protein synthesis and discusses their uses for treating respiratory infections, atypical pneumonia, and more. Common side effects include gastrointestinal issues. Azithromycin is highlighted as having expanded spectrum, improved pharmacokinetics, and convenient once daily dosing.
Antibiotic selection /certified fixed orthodontic courses by Indian dental ...Indian dental academy
This document provides information on antibiotics used for head and neck infections. It discusses the history of antibiotic discovery, classifications of antibiotics based on mechanism of action and type of organism affected, considerations for antibiotic selection such as host defenses and infection characteristics, administration principles, and potential adverse reactions. The key factors in selecting an appropriate antibiotic include the typical mixed aerobic-anaerobic oral flora, penicillin as first-line therapy, narrow-spectrum use, and parenteral administration for serious infections.
This document summarizes various antiviral drugs used to treat different viral infections. It discusses the mechanism of action, uses, and side effects of nucleoside analogues like acyclovir, valacyclovir, ganciclovir, cidofovir and ribavirin which inhibit viral DNA or RNA polymerase. It also mentions neuraminidase inhibitors oseltamivir and zanamivir used for influenza, and lamivudine, entecavir, tenofovir for chronic hepatitis B. Interferon-α used with ribavirin for hepatitis C treatment is also summarized.
Antibiotics in oral and maxillofacial surgery Firas Kassab
The document discusses antibiotics and their mechanisms and uses. It provides information on the history of antibiotics including discoveries by Pasteur, Fleming, Chain and Florey. It classifies antibiotics as bactericidal or bacteriostatic and lists examples of each. The mechanisms of different classes of antibiotics are described such as inhibiting cell wall synthesis or protein synthesis. Guidelines for antibiotic selection and factors like host defenses, toxicity, and cost are covered. Information on specific antibiotics for different infections is provided.
This document discusses cephalosporins, a class of antibiotics. It describes the different generations of cephalosporins and their antibacterial spectra. Some key points covered include: cephalosporins have similar mechanisms and resistance as penicillin; common side effects include hypersensitivity, diarrhea, and nephrotoxicity; uses include respiratory, urinary, and skin infections as well as surgical prophylaxis and meningitis; and examples are provided of cephalosporins with anti-anaerobic or anti-pseudomonal activity.
Antibiotics in oral and maxillofacial surgery /certified fixed orthodontic co...Indian dental academy
This document discusses the use of antibiotics in oral and maxillofacial surgery. It begins with definitions and classifications of antibiotics. It then covers the history of antibiotic development. The document discusses principles for choosing antibiotics, including the state of a patient's defenses, using the narrowest effective spectrum, cost, and proven efficacy. It addresses administration principles like proper dosing and timing. The therapeutic uses of various antibiotics for conditions like abscesses, osteomyelitis, and salivary gland infections are analyzed. Special considerations for pregnancy, children, liver/kidney disease are also covered. The document concludes with sections on antibiotic prophylaxis and misuse.
Vancomycin is a glycopeptide antibiotic used to treat infections caused by gram-positive bacteria such as MRSA. This 3-page document provides guidelines on vancomycin dosing and monitoring for different patient populations including neonates, infants, children, and patients with renal impairment. It outlines dosing recommendations according to indication, administration methods, monitoring for toxicity, and renal function-based dosing adjustments.
This document discusses various types of beta-lactam antibiotics including penicillins and cephalosporins. It provides information on:
- Quinolones exhibit a long post-antibiotic effect while cefpirome is a 4th generation cephalosporin.
- All drugs listed are administered orally except gentamicin. Sulbactam is not a beta-lactamase inhibitor.
- Mechanisms of action, resistance, classifications, uses, pharmacokinetics and adverse effects of different beta-lactam antibiotics like penicillins, cephalosporins, carbapenems are explained in detail. Beta-lactamase inhibitors
1) Fluoroquinolones are a class of broad-spectrum antibiotics that work by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.
2) First-generation fluoroquinolones like norfloxacin and ciprofloxacin are most active against gram-negative bacteria. Later generations have activity against gram-positives and anaerobes as well.
3) Fluoroquinolones are used to treat various bacterial infections including urinary tract infections, gastrointestinal infections, respiratory infections, and skin/soft tissue infections. They achieve high concentrations in tissues and have few drug interactions.
This document discusses the classification, mechanisms of action, resistance, and treatment guidelines for first- and second-line antitubercular drugs. It classifies drugs as first-line (isoniazid, rifampicin, pyrazinamide, ethambutol) or second-line (fluoroquinolones, aminoglycosides, cycloserine) and describes the WHO regimens for treating drug-sensitive, multidrug-resistant, and extensively drug-resistant tuberculosis. It also covers chemoprophylaxis, drug interactions, and the role of corticosteroids in tuberculosis treatment.
This document discusses antibiotic prescribing guidelines for dental infections. It recommends choosing antibiotics based on the type of infection (acute vs chronic), likely pathogens (gram positive/negative, anaerobic bacteria), patient factors (allergies, compliance) and cost-effectiveness. For acute infections less than 3 days, penicillin, amoxicillin or a cephalosporin are suitable. For chronic infections over 3 days or allergies, options include clindamycin, azithromycin/clarithromycin, or adding metronidazole to cover anaerobes. Documentation is important to justify treatment decisions.
This document discusses various antibiotics used in the ICU, including their indications, dosages, and risks. It provides risk factors for multidrug-resistant pathogens and describes important pharmacokinetic parameters for antibiotic efficacy. Key antibiotics covered include piperacillin-tazobactam, meropenem, imipenem, teicoplanin, vancomycin, clindamycin, linezolid, colistin, polymyxin B, tigecycline, trimethoprim-sulfamethoxazole, cefepime, sulbactam, amikacin, gentamicin, and metronidazole.
Ceftriaxone drug profile, drug club pptEldhose Benny
Ceftriaxone is a third generation cephalosporin antibiotic available in injectable and powder formulations. It has broad spectrum activity against gram-negative bacteria and some gram-positive bacteria. Ceftriaxone is well absorbed and widely distributed in the body with good penetration into tissues and fluids. It is partially metabolized in the liver and primarily excreted unchanged in the urine. Common indications include respiratory infections, meningitis, bone/joint infections, and intra-abdominal infections. Side effects include GI issues, hematologic effects, and hypersensitivity reactions. Dosing is 1-2g daily via IV or IM route. Drug interactions and precautions are noted with aminoglycosides, prob
Glycopeptide antibiotics like vancomycin and teicoplanin inhibit bacterial cell wall synthesis by binding to the terminal dipeptide in peptidoglycan. They are effective against gram-positive bacteria including MRSA but not gram-negatives. Linezolid and tedizolid inhibit bacterial protein synthesis and are effective against VRE and VRSA. Daptomycin is a lipopeptide antibiotic that causes cell membrane damage in gram-positives. Polypeptide antibiotics like polymyxins and bacitracin have detergent-like properties that disrupt bacterial cell membranes but are often toxic. Nitrofurantoin and methenamine are concentrated in urine and used to treat urinary tract infections without systemic effects.
Ceftriaxone 500 mg, 1g powder for solution for injection smpc taj pharmaceut...Taj Pharma
Ceftriaxone Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Ceftriaxone Dosage & Rx Info | Ceftriaxone Uses, Side Effects -: Indications, Side Effects, Warnings, Ceftriaxone - Drug Information - Taj Pharma, Ceftriaxone dose Taj pharmaceuticals Ceftriaxone interactions, Taj Pharmaceutical Ceftriaxone contraindications, Ceftriaxone price, Ceftriaxone Taj Pharma Ceftriaxone 500 mg,1g Powder for solution for injection SMPC- Taj Pharma . Stay connected to all updated on Ceftriaxone Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
This document contains multiple choice questions about antileprotic and antitubercular drugs. Some key points addressed include:
- Isoniazid is the safest antitubercular drug to use in patients with hepatitis.
- Ethambutol can cause retrobulbar neuritis.
- Rifampicin causes orange colored urine and is the most bactericidal agent for treating leprosy.
- Ethambutol is most likely to cause inability to distinguish colors if used long-term for multidrug resistant tuberculosis.
This document discusses drug therapy for malaria. It defines malaria and describes the life cycle and species of Plasmodium that cause malaria in humans. It then discusses the clinical presentation of malaria and diagnosis. The bulk of the document categorizes and describes various classes of antimalarial drugs, including quinine, chloroquine, primaquine, atovaquone, lumefantrine, and artemisinin derivatives. It provides details on the mechanisms of action, pharmacokinetics, uses, and adverse effects of many common antimalarial medications.
1. Antifungal agents target components of fungal cell walls and membranes that are different from mammalian cells, such as ergosterol in fungal cell membranes.
2. Major classes of antifungals include azoles which inhibit ergosterol synthesis, polyenes which bind to ergosterol, and echinocandins which inhibit cell wall synthesis.
3. Liposomal formulations of amphotericin B have advantages of lower toxicity compared to conventional amphotericin B due to targeted delivery to fungal cells and less interaction with human membranes.
This document discusses the increasing problem of antibiotic resistance and potential solutions. It notes the emergence of extensively drug-resistant pathogens and classifications of drug resistance. Potential solutions discussed include developing new antibiotics that target resistant bacteria, rediscovering older antibiotics, and using beta-lactamase inhibitors to enhance existing antibiotics. Several new antibiotics are summarized, including their mechanisms of action, clinical indications, and stages of clinical trials.
This document provides an overview of antibiotics commonly used in the intensive care unit in 2015. It defines key terms like minimum inhibitory concentration and pharmacodynamics. It then summarizes the mechanisms of action, dosing, and clinical pearls of various antibiotic classes including vancomycin, linezolid, daptomycin, aminoglycosides, cephalosporins, piperacillin-tazobactam, carbapenems, tigecycline, fluoroquinolones, macrolides, and tetracyclines. It highlights factors like spectrum of coverage, dosing adjustments for renal impairment, and monitoring parameters for optimal antibiotic use.
Vancomycin is an antibiotic used to treat infections caused by gram-positive bacteria like MRSA and MRSE. It works by inhibiting cell wall synthesis. It is administered intravenously and eliminated through the kidneys. Common indications include serious infections resistant to penicillin. Side effects include fever, chills, and potential ototoxicity or nephrotoxicity. Resistance has emerged through alterations of the binding site of vancomycin on bacterial cell walls.
1. The document provides information on various classes of antimicrobial drugs including penicillins, cephalosporins, and tetracyclines.
2. It describes the indications, mechanisms of action, drug interactions, and side effects of these commonly used antibiotic classes.
3. The document emphasizes that doctors should be familiar with the side effects and interactions of these drugs when treating patients.
Antibiotic selection /certified fixed orthodontic courses by Indian dental ac...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
The document discusses treatment options for a 74-year-old male patient admitted with fever, chills, and rigors who was diagnosed with urosepsis and ketoacidosis. Initial treatment with cefepime and fluconazole provided marginal benefit. Blood and urine cultures grew Candida albicans, Candida glabrata, and E. coli. The document reviews antifungal treatment options and their pros and cons, considering the patient's renal insufficiency and isolated fungal species. It recommends systemic antifungal treatment along with nephrostomy tube placement and local antifungal infusion to remove the fungal obstruction.
This presentation reviews the evaluation, diagnosis, and treatment of orofacial infections with an emphasis on antibiotic therapy and prophylaxis. It discusses assessing patients for local and systemic signs of infection. Common causative microorganisms are usually mixed aerobic and anaerobic bacteria. First-line empiric antibiotic therapy includes penicillin, cefazolin, and gentamicin. Indications for antibiotic use include infection severity, ability to drain pus, and patient immune status. Prophylactic antibiotics are recommended for certain high-risk dental procedures.
Antibiotics are commonly used therapies in critical care to optimize patient outcomes. Antibiotic stewardship programs aim to optimize antibiotic use to improve patient care while minimizing unintended consequences like antibiotic resistance. Such programs typically establish antimicrobial management teams to implement interventions like guidelines for appropriate antibiotic selection, dosing, and duration to reduce inappropriate use. However, inappropriate antibiotic use remains common, contributing to increased patient morbidity, costs and antibiotic resistance.
This document discusses the evaluation, diagnosis, and treatment of orofacial infections with an emphasis on antibiotic therapy and prophylaxis. It outlines how to assess infections through medical history, exam, and identifying signs of infection. Most oral infections involve both aerobic and anaerobic bacteria. Commonly used antibiotics include penicillin, cephalosporins, metronidazole, and clindamycin. Antibiotics should be used as an adjunct to drainage and are indicated for severe infections, inadequate drainage, or compromised hosts. Prophylactic antibiotics are recommended for high-risk dental procedures in certain patients.
Staph aureus
Strep pneumoniae
Toxicity:
Hepatotoxicity
QT prolongation
GI upset
Clarithromycin
Similar spectrum to erythromycin
Better absorption and tolerability
Used for:
H pylori eradication
Mycobacterium avium complex
Legionella
Toxicity:
Hepatotoxicity
QT prolongation
Drug interactions
No IV formulation
Azithromycin
Similar spectrum to clarithromycin
Once daily dosing
Used for
This document provides treatment guidelines for various bacterial infections. It discusses antibiotic choices for conditions like abdominal trauma, osteomyelitis, septic arthritis, prosthetic joint infections, and diabetic foot infections. It recommends broad-spectrum antibiotics as initial treatment and narrowing choices based on culture results. It emphasizes adequate treatment duration and the importance of surgical drainage or debridement for many infections. Factors like infection severity, organism type, and adequate source control influence antibiotic and treatment length decisions.
This document outlines an antibiotic policy for a hospital, with examples focusing on the central nervous system department. It provides guidance on empirical and targeted treatment for various CNS infections like meningitis, encephalitis and neurosyphilis. It also covers surgical chemoprophylaxis recommendations for different surgical site classifications from clean to contaminated. The policy aims to reduce antimicrobial resistance and ensure best practice in antibiotic use.
1) Fluoroquinolones are a class of broad-spectrum antibiotics that work by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.
2) First-generation fluoroquinolones like norfloxacin and ciprofloxacin are most active against gram-negative bacteria. Later generations have activity against gram-positives and anaerobes as well.
3) Fluoroquinolones are used to treat various bacterial infections including urinary tract infections, gastrointestinal infections, respiratory infections, and skin/soft tissue infections. They achieve high concentrations in tissues and have few drug interactions.
This document discusses the classification, mechanisms of action, resistance, and treatment guidelines for first- and second-line antitubercular drugs. It classifies drugs as first-line (isoniazid, rifampicin, pyrazinamide, ethambutol) or second-line (fluoroquinolones, aminoglycosides, cycloserine) and describes the WHO regimens for treating drug-sensitive, multidrug-resistant, and extensively drug-resistant tuberculosis. It also covers chemoprophylaxis, drug interactions, and the role of corticosteroids in tuberculosis treatment.
This document discusses antibiotic prescribing guidelines for dental infections. It recommends choosing antibiotics based on the type of infection (acute vs chronic), likely pathogens (gram positive/negative, anaerobic bacteria), patient factors (allergies, compliance) and cost-effectiveness. For acute infections less than 3 days, penicillin, amoxicillin or a cephalosporin are suitable. For chronic infections over 3 days or allergies, options include clindamycin, azithromycin/clarithromycin, or adding metronidazole to cover anaerobes. Documentation is important to justify treatment decisions.
This document discusses various antibiotics used in the ICU, including their indications, dosages, and risks. It provides risk factors for multidrug-resistant pathogens and describes important pharmacokinetic parameters for antibiotic efficacy. Key antibiotics covered include piperacillin-tazobactam, meropenem, imipenem, teicoplanin, vancomycin, clindamycin, linezolid, colistin, polymyxin B, tigecycline, trimethoprim-sulfamethoxazole, cefepime, sulbactam, amikacin, gentamicin, and metronidazole.
Ceftriaxone drug profile, drug club pptEldhose Benny
Ceftriaxone is a third generation cephalosporin antibiotic available in injectable and powder formulations. It has broad spectrum activity against gram-negative bacteria and some gram-positive bacteria. Ceftriaxone is well absorbed and widely distributed in the body with good penetration into tissues and fluids. It is partially metabolized in the liver and primarily excreted unchanged in the urine. Common indications include respiratory infections, meningitis, bone/joint infections, and intra-abdominal infections. Side effects include GI issues, hematologic effects, and hypersensitivity reactions. Dosing is 1-2g daily via IV or IM route. Drug interactions and precautions are noted with aminoglycosides, prob
Glycopeptide antibiotics like vancomycin and teicoplanin inhibit bacterial cell wall synthesis by binding to the terminal dipeptide in peptidoglycan. They are effective against gram-positive bacteria including MRSA but not gram-negatives. Linezolid and tedizolid inhibit bacterial protein synthesis and are effective against VRE and VRSA. Daptomycin is a lipopeptide antibiotic that causes cell membrane damage in gram-positives. Polypeptide antibiotics like polymyxins and bacitracin have detergent-like properties that disrupt bacterial cell membranes but are often toxic. Nitrofurantoin and methenamine are concentrated in urine and used to treat urinary tract infections without systemic effects.
Ceftriaxone 500 mg, 1g powder for solution for injection smpc taj pharmaceut...Taj Pharma
Ceftriaxone Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Ceftriaxone Dosage & Rx Info | Ceftriaxone Uses, Side Effects -: Indications, Side Effects, Warnings, Ceftriaxone - Drug Information - Taj Pharma, Ceftriaxone dose Taj pharmaceuticals Ceftriaxone interactions, Taj Pharmaceutical Ceftriaxone contraindications, Ceftriaxone price, Ceftriaxone Taj Pharma Ceftriaxone 500 mg,1g Powder for solution for injection SMPC- Taj Pharma . Stay connected to all updated on Ceftriaxone Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
This document contains multiple choice questions about antileprotic and antitubercular drugs. Some key points addressed include:
- Isoniazid is the safest antitubercular drug to use in patients with hepatitis.
- Ethambutol can cause retrobulbar neuritis.
- Rifampicin causes orange colored urine and is the most bactericidal agent for treating leprosy.
- Ethambutol is most likely to cause inability to distinguish colors if used long-term for multidrug resistant tuberculosis.
This document discusses drug therapy for malaria. It defines malaria and describes the life cycle and species of Plasmodium that cause malaria in humans. It then discusses the clinical presentation of malaria and diagnosis. The bulk of the document categorizes and describes various classes of antimalarial drugs, including quinine, chloroquine, primaquine, atovaquone, lumefantrine, and artemisinin derivatives. It provides details on the mechanisms of action, pharmacokinetics, uses, and adverse effects of many common antimalarial medications.
1. Antifungal agents target components of fungal cell walls and membranes that are different from mammalian cells, such as ergosterol in fungal cell membranes.
2. Major classes of antifungals include azoles which inhibit ergosterol synthesis, polyenes which bind to ergosterol, and echinocandins which inhibit cell wall synthesis.
3. Liposomal formulations of amphotericin B have advantages of lower toxicity compared to conventional amphotericin B due to targeted delivery to fungal cells and less interaction with human membranes.
This document discusses the increasing problem of antibiotic resistance and potential solutions. It notes the emergence of extensively drug-resistant pathogens and classifications of drug resistance. Potential solutions discussed include developing new antibiotics that target resistant bacteria, rediscovering older antibiotics, and using beta-lactamase inhibitors to enhance existing antibiotics. Several new antibiotics are summarized, including their mechanisms of action, clinical indications, and stages of clinical trials.
This document provides an overview of antibiotics commonly used in the intensive care unit in 2015. It defines key terms like minimum inhibitory concentration and pharmacodynamics. It then summarizes the mechanisms of action, dosing, and clinical pearls of various antibiotic classes including vancomycin, linezolid, daptomycin, aminoglycosides, cephalosporins, piperacillin-tazobactam, carbapenems, tigecycline, fluoroquinolones, macrolides, and tetracyclines. It highlights factors like spectrum of coverage, dosing adjustments for renal impairment, and monitoring parameters for optimal antibiotic use.
Vancomycin is an antibiotic used to treat infections caused by gram-positive bacteria like MRSA and MRSE. It works by inhibiting cell wall synthesis. It is administered intravenously and eliminated through the kidneys. Common indications include serious infections resistant to penicillin. Side effects include fever, chills, and potential ototoxicity or nephrotoxicity. Resistance has emerged through alterations of the binding site of vancomycin on bacterial cell walls.
1. The document provides information on various classes of antimicrobial drugs including penicillins, cephalosporins, and tetracyclines.
2. It describes the indications, mechanisms of action, drug interactions, and side effects of these commonly used antibiotic classes.
3. The document emphasizes that doctors should be familiar with the side effects and interactions of these drugs when treating patients.
Antibiotic selection /certified fixed orthodontic courses by Indian dental ac...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
The document discusses treatment options for a 74-year-old male patient admitted with fever, chills, and rigors who was diagnosed with urosepsis and ketoacidosis. Initial treatment with cefepime and fluconazole provided marginal benefit. Blood and urine cultures grew Candida albicans, Candida glabrata, and E. coli. The document reviews antifungal treatment options and their pros and cons, considering the patient's renal insufficiency and isolated fungal species. It recommends systemic antifungal treatment along with nephrostomy tube placement and local antifungal infusion to remove the fungal obstruction.
This presentation reviews the evaluation, diagnosis, and treatment of orofacial infections with an emphasis on antibiotic therapy and prophylaxis. It discusses assessing patients for local and systemic signs of infection. Common causative microorganisms are usually mixed aerobic and anaerobic bacteria. First-line empiric antibiotic therapy includes penicillin, cefazolin, and gentamicin. Indications for antibiotic use include infection severity, ability to drain pus, and patient immune status. Prophylactic antibiotics are recommended for certain high-risk dental procedures.
Antibiotics are commonly used therapies in critical care to optimize patient outcomes. Antibiotic stewardship programs aim to optimize antibiotic use to improve patient care while minimizing unintended consequences like antibiotic resistance. Such programs typically establish antimicrobial management teams to implement interventions like guidelines for appropriate antibiotic selection, dosing, and duration to reduce inappropriate use. However, inappropriate antibiotic use remains common, contributing to increased patient morbidity, costs and antibiotic resistance.
This document discusses the evaluation, diagnosis, and treatment of orofacial infections with an emphasis on antibiotic therapy and prophylaxis. It outlines how to assess infections through medical history, exam, and identifying signs of infection. Most oral infections involve both aerobic and anaerobic bacteria. Commonly used antibiotics include penicillin, cephalosporins, metronidazole, and clindamycin. Antibiotics should be used as an adjunct to drainage and are indicated for severe infections, inadequate drainage, or compromised hosts. Prophylactic antibiotics are recommended for high-risk dental procedures in certain patients.
Staph aureus
Strep pneumoniae
Toxicity:
Hepatotoxicity
QT prolongation
GI upset
Clarithromycin
Similar spectrum to erythromycin
Better absorption and tolerability
Used for:
H pylori eradication
Mycobacterium avium complex
Legionella
Toxicity:
Hepatotoxicity
QT prolongation
Drug interactions
No IV formulation
Azithromycin
Similar spectrum to clarithromycin
Once daily dosing
Used for
This document provides treatment guidelines for various bacterial infections. It discusses antibiotic choices for conditions like abdominal trauma, osteomyelitis, septic arthritis, prosthetic joint infections, and diabetic foot infections. It recommends broad-spectrum antibiotics as initial treatment and narrowing choices based on culture results. It emphasizes adequate treatment duration and the importance of surgical drainage or debridement for many infections. Factors like infection severity, organism type, and adequate source control influence antibiotic and treatment length decisions.
This document outlines an antibiotic policy for a hospital, with examples focusing on the central nervous system department. It provides guidance on empirical and targeted treatment for various CNS infections like meningitis, encephalitis and neurosyphilis. It also covers surgical chemoprophylaxis recommendations for different surgical site classifications from clean to contaminated. The policy aims to reduce antimicrobial resistance and ensure best practice in antibiotic use.
This document provides an overview of antibiotics commonly used in the intensive care unit in 2015. It defines key terms like minimum inhibitory concentration and pharmacodynamics. It then summarizes the mechanisms of action, dosing, and clinical pearls of various antibiotic classes including vancomycin, linezolid, daptomycin, aminoglycosides, cephalosporins, piperacillin-tazobactam, carbapenems, tigecycline, fluoroquinolones, macrolides, and tetracyclines. It highlights factors like spectrum of coverage, dosing adjustments for renal impairment, monitoring parameters, and when certain antibiotics should be reserved for more resistant infections.
Superinfections occur when a new infection develops due to antimicrobial therapy weakening the normal microbiota. This allows overgrowth of resistant organisms. Predisposing conditions include corticosteroid use, immunosuppression, and broad-spectrum antibiotics. Common superinfecting organisms are Candida, Clostridium difficile, HCV, HIV, and Aspergillus. Candida commonly causes oral and vulvovaginal infections treatable with antifungals. C. difficile causes diarrhea treatable with vancomycin or fidaxomicin. Aspergillus may complicate lung disease and is managed with antifungals and steroids.
This document discusses Methicillin-resistant Staphylococcus aureus (MRSA), including types (community-acquired and hospital-acquired), resistance mechanisms, infections it commonly causes, and treatment guidelines. MRSA is resistant to many antibiotics. Recommended treatments include vancomycin, daptomycin, linezolid, clindamycin, and combining antibiotics with rifampin. For infections like osteomyelitis and implant infections, guidelines recommend antibiotics along with surgical debridement and drainage. Duration of treatment depends on infection type and severity but is typically several weeks.
Pneumonia is an inflammation of the lungs that is often caused by an infection. Common symptoms include fever, cough, chest pain, and shortness of breath. Chest x-rays are used to confirm pneumonia. There are several types including community-acquired pneumonia (CAP), which occurs outside of hospitals, and hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), which occur in hospital patients. Initial treatment depends on severity and risk factors, and may involve antibiotics alone or in combination to treat common causative organisms like streptococcus pneumoniae, staphylococcus aureus, and pseudomonas aeruginosa. Guidelines provide scoring systems and recommendations for empiric antibiotic therapy based on the type and severity
This document discusses various therapeutics used in dentistry, focusing on antibiotics. It defines key terms related to antimicrobial drugs and provides an overview of common antibiotics used, including beta-lactams, aminoglycosides, glycopeptides, tetracyclines, macrolides, metronidazole, quinolones, and antitubercular drugs. It also covers indications for antibiotic use, treatment of infections, prophylactic use, routes of administration, treatment failure, antifungals, and antivirals.
This document defines key terms related to antimicrobial drugs and provides guidance on their appropriate use. It discusses:
1. Common types of antimicrobial drugs including antibacterial, antiviral, antifungal, and antiparasitic.
2. Characteristics of broad and narrow spectrum antibacterials.
3. Mechanisms of action for killing or inhibiting bacterial growth.
4. Examples of common antibiotics and their indications.
5. Factors to consider when selecting an antibiotic for odontogenic infections.
This document discusses MRSA (Methicillin-resistant Staphylococcus aureus) in orthopaedic surgery. It covers the emergence of resistance to penicillin and methicillin over time. There are two main types of MRSA - CA-MRSA acquired in the community and HA-MRSA acquired in healthcare settings. Prevention strategies discussed include using mupirocin ointment to eliminate nasal carriers, and administering vancomycin or antibiotic-impregnated bone cement for prophylaxis. Newer antibiotics discussed for treating MRSA include daptomycin, linezolid, and alternative delivery methods beyond systemic antibiotics.
This document discusses the use of antibiotics in oral and maxillofacial surgery. It begins with an introduction and overview of antibiotic classification, mechanisms of action, principles of use, and indications. It then covers specific topics like empirical therapy, combination therapy, special patient populations, surgical wound classification, antibiotic resistance, and newer antibiotics. The key points are that antibiotics are generally used to treat established infections, as prophylaxis for high-risk procedures, and that principles of prudent use include narrow-spectrum therapy based on culture and sensitivity testing when possible.
This document discusses Meningococcal disease, which is caused by the bacterium Neisseria meningitidis. It can cause meningitis (infection of the brain lining) or meningococcal septicemia (blood infection). The disease is transmitted through respiratory secretions. Specimens should be collected from patients for diagnosis. Morphologically, N. meningitidis appears as gram-negative oval or spherical diplococci. It grows on blood and chocolate agar. Antibiotic prophylaxis should be given within 24 hours to exposed individuals. Recommended antibiotics include rifampin, ciprofloxacin, or ceftriaxone. Health care workers caring for patients must take precautions
Febrile neutropenia - Infections in cancer patientsAli Musavi
This document discusses infections in cancer patients, with a focus on febrile neutropenia. It describes how the mortality rate from infection in febrile neutropenic patients has dropped dramatically to under 10% due to early empirical antibiotic therapy and the addition of empirical antifungal therapy. It provides guidelines for evaluating and managing low-risk versus high-risk febrile neutropenic patients, including recommended antimicrobial regimens. It also discusses specific infections like pulmonary infections and their diagnosis.
1. Guidelines for the rational use of antibiotics and.pptxAnusha Are
Guidelines for the rational use of antibiotics and surgical prophylaxis provide definitions and guidelines around antibiotic use for surgery. They discuss defining surgery and why antibiotics are needed, risk factors that promote infection, classifying surgical wounds, and goals of antibiotic prophylaxis including reducing surgical site infections. The guidelines provide recommendations on antibiotic selection, timing of administration before and after surgery, and dosing to effectively prevent infections while minimizing antibiotic resistance and costs.
1) The document discusses various antibiotics used to treat gram positive and gram negative bacteria, including vancomycin, linezolid, daptomycin, aminoglycosides, aztreonam, cephalosporins, piperacillin-tazobactam, carbapenems, tigecycline, and atypical agents.
2) It provides information on the spectrum of activity, mechanisms of action, dosing, and clinical pearls for each antibiotic class.
3) Key points covered include time and concentration dependent antibiotic killing, monitoring of vancomycin and aminoglycoside levels, extended infusion of meropenem, and reserving tigecycline
This document provides an overview of antibiotics used to treat maxillofacial infections. It discusses the history and classification of antibiotics, principles for choosing the appropriate antibiotic, administration of antibiotics, combination antibiotic therapy, antibiotic prophylaxis and its principles. It also discusses some of the most commonly used antibiotics for maxillofacial infections such as penicillin, cephalosporins, and tetracyclines. Specific antibiotics discussed in more detail include amoxicillin, penicillin VK, and minocycline.
1. Early recognition and treatment of endophthalmitis is critical to prevent further spread and vision loss. Diagnosis involves a thorough ocular exam, microbiological investigations including aqueous or vitreous taps and cultures, as well as systemic workup to identify the source of infection.
2. Treatment involves prompt administration of broad-spectrum intravitreal antibiotics targeting both gram-positive and gram-negative organisms. Vitrectomy may improve outcomes in cases with initial light perception vision or suspected fungal infection. Close monitoring is needed as repeat injections or surgery may be required if the infection persists or vision declines.
3. Risk factors like older age, diabetes, and poor initial vision portend worse visual outcomes,
HIV AND OPPORTUNISTIC INFECTIONS IN HIV.pptxdrsriram2001
Definition
Opportunistic infections (Ols) are infections that occur more often or are more severe in people with weakened immune systems (people living with HIV) than in people with healthy immune systems.
The document provides guidelines for parenteral to oral conversion of antibiotics, antibiotic treatment protocols for various infections, and considerations for antibiotic stewardship. It discusses converting IV antibiotics to oral when patients are clinically improving after 48 hours on IV regimen if they can tolerate oral medications. For treatment of infections like pneumonia and bloodstream infections, it recommends broad-spectrum IV antibiotics like meropenem or piperacillin-tazobactam along with antibiotics like vancomycin or azithromycin based on severity and suspected pathogens. It stresses the importance of de-escalating antibiotics when possible and considering the AWaRe antibiotic classification of Watch and Reserve antibiotics for more resistant infections.
This document discusses lower respiratory tract infections, specifically pneumonia. It defines different types of pneumonia including community-acquired, hospital-acquired, and ventilator-associated pneumonia. It covers the pathophysiology, clinical presentation, diagnosis, treatment including empiric antibiotic regimens, and prevention of pneumonia. Empiric therapy and treatment duration depends on the type and severity of pneumonia as well as patient risk factors and comorbidities. The goal of treatment is to promptly administer appropriate empiric antibiotics, tailor definitive therapy based on pathogen identification, and limit therapy duration to reduce collateral antibiotic damage.
Neutropenic sepsis is a life-threatening condition seen in patients with very low neutrophil counts. The document defines fever and the different levels of neutropenia. It outlines the diagnostic evaluation of patients with fever and neutropenia which includes blood cultures, microbiological testing, and imaging if a site of infection is suspected. Empiric antibiotic therapy should have broad gram-negative and gram-positive coverage and be given immediately. The initial antibiotic regimen is discussed as well as modifications based on clinical response. The duration of empiric therapy depends on resolution of fever and bone marrow recovery. Catheter removal is recommended for certain infections. Colony stimulating factors are not routinely recommended for established fever and neutropenia.
Similar to Antibiotic therapy in musculoskeletal infection (20)
The document discusses prophylaxis for deep vein thrombosis (DVT). It defines DVT and describes its pathophysiology. Risk factors for DVT include surgery, immobilization, old age, cancer, and inherited or acquired thrombophilias. Without prophylaxis, DVT can occur in 40-60% of major orthopedic surgeries and lead to pulmonary embolism. Methods of prophylaxis include mechanical methods like mobilization and compression devices as well as pharmacological methods like low molecular weight heparin, factor Xa inhibitors, and vitamin K antagonists. Guidelines recommend different prophylaxis options based on surgery type and patient risk factors
This document discusses fragility fractures caused by osteoporosis. It defines fragility fractures as fractures caused by a fall from standing height. Osteoporosis is characterized by low bone mass and deterioration of bone structure, increasing risk of fractures. The document reviews diagnosis of osteoporosis using DXA scans, risk factors, management including lifestyle changes and medications, and challenges of treating fragility fractures in osteoporotic patients. It emphasizes the importance of rehabilitation and secondary prevention including fall prevention and osteoporosis treatment to prevent further fractures.
1) Septic arthritis is a orthopaedic emergency caused by bacterial or other infectious agents invading the joint space. Without prompt antibiotic treatment and drainage, it can cause permanent joint damage or systemic infection.
2) Risk factors include young age, existing joint problems, immunosuppression, skin conditions, and IV drug use. The knee and hip are most commonly affected.
3) Clinical features include acute pain, swelling, warmth, and limited movement of the infected joint. Blood tests may show elevated inflammatory markers. Joint fluid analysis is required for diagnosis.
4) Treatment involves antibiotics, joint drainage, and sometimes surgery. Outcomes depend on early diagnosis and intervention, with possible sequelae including fibrosis, anky
1) The document discusses various measurements and anatomical landmarks used to assess lower limb alignment and deformities around the knee. It describes how to evaluate the hip, knee, and ankle joints, including joint orientation lines, center points, and anatomical and mechanical axes.
2) Methods for evaluating knee alignment include the mechanical axis deviation (MAD), anatomical tibiofemoral angle, and malalignment test (MAT). Common deformities like varus, valgus, and condylar malalignment are defined.
3) Techniques are provided for evaluating uni-apical and multi-apical tibial and femoral deformities, including identifying the center of rotation of angulation (CORA) and measuring the magnitude of
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Debunking Nutrition Myths: Separating Fact from Fiction"AlexandraDiaz101
In a world overflowing with diet trends and conflicting nutrition advice, it’s easy to get lost in misinformation. This article cuts through the noise to debunk common nutrition myths that may be sabotaging your health goals. From the truth about carbohydrates and fats to the real effects of sugar and artificial sweeteners, we break down what science actually says. Equip yourself with knowledge to make informed decisions about your diet, and learn how to navigate the complexities of modern nutrition with confidence. Say goodbye to food confusion and hello to a healthier you!
4. Selection of Antibiotic
• Type of infection
• Culture / Sensitivity
• Hospital sensitivity patterns,
• Risk vs benefit
5. Routes
• Oral - most commonly used.
• Intravenous - serious infections
• Local delivery
6. Soft Tissue Infection
• Most common- staph areus, staph epidermidis,
strep pyogenes
• MRSA has increased incidence
7. Drug Doses
GRAM POSITIVE
• Frist choice- Neficillin 2g 6hrly or Clindamycin 900mg 8hrly
• Alternate – Vancomycin 500mg 8hrly or Cephalothin
• MRSA- Vancomycin 500mg TID or Neficillin
• Group A and B Staph: Penicillin G 2* 4hrly
• 2nd choice- Clindamycin or Cephalothin
• Enterococcus- Ampicillin 2gm 6hrly
• 2nd choice Vancomycin
9. Osteomyelitis
• Infection of the bone
• Types- Acute or Chronic
• Haematogenic or Exogenous
• Pyogenic or Granulomatous
10. Location
• Tubular bones with most rapid growth and largest metaphyses
are most commonly affected, 75%
• Femur > tibia > fibula; distal end > proximal end
• Flat bones are less frequently infected, 25%
• Neonates : metaphysis and/or epiphysis
• Children : metaphysis
• Adults : epiphyses and subchondral regions
11. MC isolated organism
• <1 yr- Group B streptococcus,
• <1 yr- Group B streptococcus, Staph.aureus, E.coli
Staph.aureus, E.coli
• 1 to 16 yr- Staph.aureus, Strep.pyogenes
• >16yr- Staph.aureus, Strep.epidermidis
• >16yr- Staph.aureus, Strep.epidermidis,
Pseudomonas, E.coli, Serratiamarcescens
12. Treatment
• Flucloxacilin and ampicilin started iv
• Continue until blood c/s report
• Antibiotic for 6weeks
• Monitor ESR
13. PMMAAntibiotic Bead Chains
• Local concentrations of antibiotic achieved are 200 times
higher
• Aminoglycosides - most commonly employed antibiotics for
use with PMMA beads
• Currently, most commercially available bone cements have a
prepackaged form available with gentamicin (500 mg/40g
pack).
• We generally add 2 to 4 g of vancomycin, with or without 1 g
of tobramycin, to each 40g pack before adding the monomer
14.
15. Septic Arthritis
• S. aureus is most frequently isolated
• N. gonorrhoeae is more common in adults younger than
30 years
• H. influenzae type B is more common in children
younger than 2 years.
16. • Trial of antibiotic treatment is appropriate only after culture
material has been obtained.
• If the patient does not respond to antibiotic treatment in 36 to
48 hours, the wrong antibiotic has been chosen or an abscess
has formed
• After 48 hours, specific antibiotic can be chosen
• If an abscess has formed, surgery is indicated.
17. Periprosthetic Infection
Definition:
• There is a sinus tract communicating with the
prosthesis; or
• A pathogen is isolated by culture from at least two
separate tissue or fluid samples obtained from the
affected prosthetic joint; or
18. Four of the following six criteria exist:
• Elevated (ESR) and (CRP) ,
• (b) Elevated synovial leukocyte count,
• (c) Elevated synovial PMN%,
• (d) Presence of purulence in the affected joint,
• (e) Isolation of a microorganism in one culture of
periprosthetic tissue or fluid, or
• (f) Greater than five neutrophils per high-power field in five
high-power fields
19.
20.
21. Microorganism Preferred Treatmenta Alternative Treatmenta
Staphylococci, oxacillin-
susceptible
Nafcillinb sodium 1.5–2 g IV q4-6 h Vancomycin IV 15 mg/kg q12 h
or or
Cefazolin 1–2 g IV q8 h Daptomycin 6 mg/kg IV q 24 h
or or
Ceftriaxonec 1–2 g IV q24 h Linezolid 600 mg PO/IV every 12 h
Staphylococci, oxacillin-
resistant
Vancomycind IV 15 mg/kg q12 h
Daptomycin 6 mg/kg IV q24 horLinezolid
600 mg PO/IV q12 h
Enterococcus spp,
penicillin-susceptible
Penicillin G 20–24 million units IV q24 h
continuously or in 6 divided doses
or
Ampicillin sodium 12 g IV q24 h
continuously or in 6 divided doses
Vancomycin 15 mg/kg IV q12 h
or
Daptomycin 6 mg/kg IV q24 h
or
Linezolid 600 mg PO or
IV q12 h
Enterococcus spp,
penicillin-resistant
Vancomycin 15 mg/kg IV q12 h
Linezolid 600 mg PO or
IV q12 h
or
Daptomycin 6 mg IV q24 h
Pseudomonas
aeruginosa
Cefepime 2 g IV q12 h Ciprofloxacin 750 mg PO bid
or or 400 mg IV q12 h
Meropeneme 1 g IV q8 h or
Ceftazidime 2 g IV q8 h
22. Prophylactic Antibiotic Therapy
• During the first 24 hours, infection depends on the
number of bacteria present
• During the first 2 hours, the host defense mechanism
works to decrease the overall number of bacteria
• During the next 4 hours, the number of bacteria remains
fairly constant
• These first 6 hours are called the “golden period,” after
which the bacteria multiply exponentially
23. • Begin immediately before surgery (ideally 30 minutes before skin
incision).
• A maximal dose of antibiotic should be given and can be repeated
every 4 hours intraoperatively or whenever the blood loss exceeds
1000 to 1500 mL.
• Little is gained by extending antibiotic coverage over 24 hours.
• m/c used is 2nd generation cephalosporins.
• β-lactams such as cephalosporins, penicillin and its derivatives
such as cloxacillin, glycopeptides - teicoplanin and
aminoglycosides - gentamicin.
25. Cefuroxime
• Second-generation cephalosporin
• susceptible to beta-lactamase
• greater activity against Staph Areus, Haemophilus
influenzae, Neisseria gonorrhoeae
• Side effect: diarrhea, nausea, vomiting,
headaches/migraines, dizziness, and abdominal pain
26. Vancomycin
• Glycopeptide antibiotic
• Surgical prophylaxis/treatment for major procedures
involving implantation of prostheses in institutions with a
high rate of MRSA or MRSE
• MIC
S. aureus: 0.25 μg/ml to 4.0 μg/ml
S. aureus (methicillin resistant or MRSA): 1 μg/ml to 138 μg/ml
S. epidermidis: ≤0.12 μg/ml to 6.25 μg/ml
27. • SIDE EFFECT:
Anaphylaxis
Toxic epidermal necrolysis
Erythema multiforme
Red man syndrome
Thrombocytopenia
Neutropenia
Ototoxic
Nephrotoxic
29. System organ classCommon
(≥1/100 to <1/10 )
Uncommon
(≥1/1,000 to <1/100)
Rare
(≥1/10,000 to <1/1,000)
Infections and
infestations
Abscess
Blood and the
lymphatic system
disorders
Leucopenia, thrombocytopenia,
eosinophilia
Immune system
disorders
Anaphylactic reaction (anaphylaxis)
Nervous system
disorders
Dizziness, headache
Ear and Labyrinth
disorders
Deafness, hearing, tinnitus, vestibular
disorder
Vascular disorders Phlebitis
Respiratory,
thoracic and
mediastinal
disorders
Bronchospasm
Gastro-intestinal
disorders
Diarrhoea, vomiting, nausea
Skin and
subcutaneous tissue
disorders
Rash, erythema, pruritus Red man syndrome (e.g.
Flushing of the upper part
of the body)
Renal and Urinary
disorders
Blood creatinine increased
31. • Side effects:
• Most nephrotoxic of the class
• Ototoxic
• Low blood counts
• Allergic responses
• Neuromuscular problems
• Nerve damage
32. Linezolid
• Oxazolidinone class
• Protein synthesis inhibitor
• Resistant gram positive bacteria
• 600 mg IV or orally every 12 hours
33. Side effect:
• Severe diarrhea or diarrhea that is watery or bloody
• Fungal infections
• Thrombocytopenia
• Myelosuppression
• Serotonin syndrome
• Nerve problems
• Angioedema
• Fever, chills, body aches, flu symptoms
Musculoskeletal infections are classified according to the affected structures in:
Alternate
• Mezlocilin, Imipenem, amikacin,Mezlocilin,, Ceforoxime, Ceftazidime•
Anaerobic-• Clindamycin 900mg •
Pencillin G 2 X 10Pencillin G 2 X 4hrly •
Alternate- Metronidazole, Cefoxitine
Penicillins, cephalosporins, and clindamycin are eluted well from PMMA beads;
vancomycin elutes much less effectively
Antibiotics such as the fluoroquinolones, tetracycline, and polymyxin B are broken down during the exothermic process of cement hardening and should not be used with PMMA beads
Whiteside et al. described a one-stage débridement
and revision with a cementless prosthesis and intraarticular infusion of vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) infections. After débridement and implantation of the prosthesis, patients received two 1-g doses of vancomycin intravenously over 24 hours, and then only intraarticular infusion of vancomycin, keeping blood levels between 3 and 10 µg/mL. Seventeen of 18 documented MRSA infections were successfully treated using this technique, as was one recurrent infection.
Parvizi, Javad & Zmistowski, Benjamin & Berbari, Elie & W Bauer, Thomas & Springer, Bryan & J Della Valle, Craig & L Garvin, Kevin & Mont, Michael & Wongworawat, Montri & G Zalavras, Charalampos. (2011). New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society. Clinical orthopaedics and related research. 469. 2992-4. 10.1007/s11999-011-2102-9.
Enterobacter spp
Cefepime 2 g IV q12 h or Ertapenem 1 g IV q24 h
Ciprofloxacin 750 mg PO or 400 mg IV q12 h
Enterobacteriaceae
IV β-lactam based on in vitro susceptibilities or Ciprofloxacin 750 mg PO bid
β-hemolytic streptococci
Penicillin G 20–24 million units IV q24 h continuously or in 6 divided doses or Ceftriaxone 2 g IV q24 h
Vancomycin 15 mg/kg IV q12 h
Propionibacterium acnes
Penicillin G 20 million units IV q24 h continuously or in 6 divided doses or Ceftriaxone 2 g IV q24 h
Clindamycin 600–900 mg IV q8 h or clindamycin 300–450 mg PO qid or Vancomycin 15 mg/kg IV q12 h
During the first 24 hours, infection depends on the number of bacteria present. During the first 2 hours, the host defense mechanism works to decrease the overall number of bacteria. During the next 4 hours, the number of bacteria remains fairly constant, with the bacteria that are multiplying and the bacteria that are being killed by the host defenses being about equal. These first 6 hours are called the “golden period,” after which the bacteria multiply exponentially. Antibiotics decrease bacterial growth geometrically and delay the reproduction of the bacteria. The administration of prophylactic antibiotics expands the golden period.
Namias et al. found that antibiotic coverage for longer than 4 days led to increased bacteremia and intravenous line infections in patients in intensive care units. Evidence now shows that 24 hours of antibiotic administration is just as beneficial as 48 to 72 hours.
cefazolin was the most used antibiotic in preoperative prophylaxis, combination of cefazolin with gentamicin was the second common regimen while 3rd generation cephalosporin were 3rd widely used antibiotics.2 National clinical practice guidelines on rationale use of antibiotics in orthopedic surgery in Malaysia recommends cloxacillin in combination with gentamicin as first choice, 2nd generation cephalosporin as second choice antibiotics in arthroplasty and open reduction and internal fixation of fracture
The trend in western literature is to use 2nd generation cephalosporins (cefuroxime) prophylactic antibiotics 30 min to 1 h before skin incision and preferable for 24 h to 3 days in intravenous infusion postoperatively
Cefuroxime has high bioavailability in tissue and serum after a single dose and is efficacious for preventing perioperative infection.
Early in treatment as an empiric antibiotic for possible MRSA infection while waiting for culture identification of the infecting organism
ncluding Pseudomonas, Proteus, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Serratia, and the Gram-positive Staphylococcus.[9]
Enterococcus faecium and Enterococcus faecalis (including vancomycin-resistant enterococci), Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus, MRSA), Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, the viridans group streptococci, Listeria monocytogenes, and Corynebacterium